
Danaher Corporation reported a 60% year-over-year increase in Q2 2026 net earnings to $870 million, driven by strong core growth and the early completion of its Masimo acquisition. Revenues rose 5.5% to $6.3 billion, with adjusted earnings per share up 8% to $1.94. The company raised its full-year adjusted earnings per share guidance to $8.45-$8.60, expecting mid-single-digit core revenue growth by year-end. Danaher highlighted robust Life Sciences performance and ongoing market recovery as key growth drivers.